Mycophenolate mofetil as adjuvant in pemphigus vulgaris

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 5, 2007, Pages 348-350

  Sarma, Nilendu ^a,b   Ghosh, Sanjay ^a  

^a Institute of Allergic and Immunologic Skin Diseases   (India)

^b P N Colony   (India)

Author keywords

Mycophenolate mofetil; Pemphigus vulgaris

Indexed keywords

ANTIFUNGAL AGENT; AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ABDOMINAL DISCOMFORT; ADJUVANT THERAPY; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INDIA; LABORATORY TEST; MALE; MONOTHERAPY; NAUSEA; OPPORTUNISTIC INFECTION; PEMPHIGUS VULGARIS; PHYSICAL EXAMINATION; PROGNOSIS; SYMPTOM; THRUSH; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 35048861804     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.35740     Document Type: Article

References (11)

1. Stanley JR. Therapy of pemphigus vulgaris. Arch Dermatol, 1999;133:76-9.
2. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus: an update. Arch Dermatol, 1996;133:203-5.
3. Fine JD. Management of acquired bullous skin diseases. N Eng J Med, 1995;333:1475-7.
4. Enk AH, Knop J. Mycophenolate mofetil is effective in the treatment of pemphigus vulgaris. Arch Dermatol, 1998;135:54-6.
5. Korman MJ. New and emerging therapies in the treatment a blistering diseases. Dermatology Clinics 2000; 18: 127-137
6. Bredlich RO, Grundmann-Kollmann M, Behrens S, Kerscher M, Peter RU. Mycophenolate mofetil monotherapy for pemphigus vulgaris.Br J Dermatol. 1999;141(5):934.
7. Grundman-Kollmann M, Korting HC, Behrens S, et al. Mycophenolate mofetil. A new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol 1999; 40: 957-960
8. Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol. 2003;139(6):739-42.
9. Powell AM, Albert S, Al Fares S, Harman KE, Setterfield J, Bhogal B, Black MM. An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Br J Dermatol. 2003;149(1):138-45.
10. Nousari HC, Sragovich A, Kiyai Asadi A, et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 1999; 40: 265-8.
11. Pan TD, McDonald CH. Cytotoxic agents. In: Wolverton SE, editor. Comprehensive Dermatologic Drug Therapy. Philadelphia: WB Saunders, 2001:180-204.